Note 6 - Per Share Amounts

9 Months Ended

Sep. 30, 2022

Notes to Financial Statements

Earnings Per Share [Text Block]

Note 6.    Per Share Amounts

Per share information has been computed based on the weighted average number of common shares and dilutive common share equivalents outstanding. Based on the guidance provided in accordance with ASC 260 Earnings Per Share (“ASC 260”), potentially dilutive common stock equivalents, such as diluted stock options, are not considered when their inclusion in reporting earnings per share would be dilutive to reported losses incurred per share. Because the Company reported a loss for the nine-month period ended  September 30, 2021, the potentially dilutive effects of approximately 48,000, of the Company’s stock options and 13,000 of the Company's unvested restricted stock awards were not considered for the reporting periods. 

The computation for the three and nine-month periods ended September 30, 2022 excluded approximately 91,000 and 91,000, respectively, of the Company’s stock options because the exercise price of the options was higher than the average market price during the period. The computation for the three-month period ended  September 30, 2021 excluded approximately 346,000 of the Company’s stock options because the exercise price of the options was higher than the average market price during the period. The weighted average common shares outstanding for basic earnings per share for the three and nine-month periods ended September 30, 2022 included approximately 123,000 and 123,000, respectively, of the Company's restricted stock awards that are fully vested but are deferred for issuance. The weighted average common shares outstanding for basic earnings per share for the three-month period ended  September 30, 2021 included approximately 235,000 of the Company's restricted stock awards that are fully vested but are deferred for issuance.

The following table sets forth the computation of basic and diluted earnings per share for the three and nine-month periods ended September 30, 2022 and 2021:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Net income (loss) attributable to American Shared Hospital Services	$	316,000	$	33,000	$	1,082,000	$	(25,000	)
Weighted average common shares for basic earnings (loss) per share		6,234,000		6,103,000		6,223,000		5,824,000
Dilutive effect of stock options and restricted stock awards		39,000		20,000		38,000		-
Weighted average common shares for diluted earnings (loss) per share		6,273,000		6,123,000		6,261,000		5,824,000
Basic earnings (loss) per share	$	0.05	$	0.01	$	0.17	$	(0.00	)
Diluted earnings (loss) per share	$	0.05	$	0.01	$	0.17	$	(0.00	)